循環器ジャーナル67巻2号

2019年04月発行

特集 心疾患治療としての心臓リハビリテーション Ⅲ．各種疾患の心臓リハビリテーション

狭心症—有意狭窄病変がある場合

著者： 安達仁¹

所属機関： ¹群馬県立心臓血管センター

ページ範囲：P.250 - P.259

Point
・安定狭心症が心筋梗塞になる率はPCIを行っても行わなくても変わらない．
・狭心症の症状は心臓リハビリテーションにより消失させることができる．
・新規病変発症率は心臓リハビリテーションを行うと1/5に減る．

参考文献

1) Evans DL, Charney DS, Lewis L, et al:Mood disorders in the medically ill:scientific review and recommendations. Biol Psychiatry 58:175-189, 2005

2) Stewart RH, Colquhoun DM, Marschner SL, et al:Persistent psychological distress and mortality in patients with stable coronary artery disease. Heart 103:1860-1866, 2017

3) Falk E, Shah PK, Fuster V:Coronary plaque disruption. Circulation 92:657-671, 1995

4) Boden WE, O'Rourke RA, Teo KK, et al:Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503-1516, 2007

5) De Bruyne B, Pijls NH, Kalesan B, et al:Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991-1001, 2012

6) Nishigaki K, Yamazaki T, Kitabatake A, et al:Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv 1:469-479, 2008

7) Al-Lamee R, Thompson D, Dehbi H-M, et al:Percutaneous coronary intervention in stable angina（ORBITA）:a double-blind, randomised controlled trial. Lancet 391:31-40, 2018

8) Lindner V, Fingerie J, Reidy MA:Mouse model of arterial injury. Circ Res 73:792-796, 1993

9) Kim LK, Feldman DN, Swaminathan RV, et al:Rate of Percutaneous Coronary Intervention for the Management of Acute Coronary Syndromes and Stable Coronary Artery Disease in the United States（2007 to 2011）. Am J Cardiol 114:1003-1010, 2014

10) Benjamin EJ, Virani SS, Callaway CW, et al:Heart Disease and Stroke Statistics-2018 Update:A Report From the American Heart Association. Circulation 137:e67-e492, 2018

11) Hisagi M, Ohno T, Takamoto S, et al:Medical Costs during 2 Years after CABG or DES Implantation for Stable Coronary Disease in Non-Diabetic Patients. J Cardiol Jpn Ed 3:113-117, 2009

12) Ornish D, Scherwitz LW, Billings JH, et al:Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280:2001-2007, 1998

13) Gielen S. Hambrecht R:Effects of exercise training on vascular function and myocardial perfusion. Circulation 19:357-368, 2001

14) Pearson MJ, Mungovan SF, Smart NA:Effect of aerobic and resistance training on inflammatory markers in heart failure patients:systematic review and meta-analysis. Heart Fail Rev 23:209-223, 2018

15) Hong MK, Park DW, Lee CW, et al:Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. J Am Coll Cardiol Intv 2:679-688, 2009

16) Hambrecht R, Adams V, Erbs S, et al:Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107:3152-3158, 2003

17) Wang JS, Jen CJ, Chen HI:Effects of exercise training and deconditioning on platelet function in men. Arterioscler Thromb Vasc Biol 15:1668-1674, 1985

18) Kupchak BR, Creighton BC, Aristizabal JC, et al:Beneficial effects of habitual resistance exercise training on coagulation and fibrinolytic responses. Thromb Res 131:e227-e234, 2013

19) Fisher M:Diabetes and atherogenesis. Heart 90:336-340, 2004

20) 橋本淳，後藤忠雄，内堀充敏，他：高脂血症治療薬による日本人の虚血性心疾患の予防効果とリスク．動脈硬化26:157-164, 1998

21) Sabatine MS, Giugliano RP, Keech AC, et al:Evolcumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376:1713-1722, 2017

22) Dudley GA, Abraham WM, Terjung RL:Influence of exercise intensity and duration on biochemical adaptations in skeletal muscle. J Appl Physiol Respir Environ Exerc Physiol 53:844-850, 1982